"Beautiful young people are works of nature, but beautiful old people are works of art.”
The facial aesthetics industry comprising of dermal fillers and injectables is estimated at 5Bn USD globally with a projected growth rate of 11% CAGR till 2023. Facial aesthetics, being a niche therapeutic category, is a high value, low volume industry with limited players.
Xeina Aesthetics, the vertical of Xeina Drugs focussed purely on aesthetics, offers high quality dermal fillers with CE certification and all documentation for global licensing. Xeina has exclusive rights for India and global rights granted for its products portfolio.